Piringer-Kuhinki Syndrome

"Piringer-Kukhinki syndrome" is a rare genetic disease that occurs in people with disorders of the lymphatic system. This condition is characterized by inflammatory processes in the lymph nodes, an increased risk of developing lymphomas and other cancers.

This condition was first described in 1886 by a German pathologist, Otto Pingner, who described severe inflammation in the lymphatic system associated with malignancy. Later, in 1935, a French pathologist, Marc Kuhinck, supplemented this description and expanded it to the entire body.

Piringer and Kuhinke syndrome are characterized by the development of a tumor in a lymph node that is located in the neck. The tumor can develop on one or more nodes in different parts of the neck. This causes a sore throat, swelling in the neck and increased salivation. In addition, the disease may cause changes in the organs of vision and hearing, weakness, general deterioration and weight loss.

Treatment of the disease requires surgery, as well as chemotherapy and radiation therapy to shrink the tumor and eliminate possible complications. Patients suffer from serious illnesses and must monitor their health constantly throughout their lives. However, there is a risk that the disease may return even if all necessary procedures have been completed

Piringer-Kukhinki syndrome is a hereditary disease that is characterized by a violation of metabolic regulation processes associated with the intake and consumption of glucose. The syndrome was discovered and described in 1892 by German pathologist Johann Piringer and Austrian professor of physiology Joseph Kuchinke. Piringer and Kuhinke coined the term "Piringer-Kuhinke syndrome" back in 1879 and studied the metabolic disorder in the heads of mice for many years before confirming its existence in humans.

Piringer believes that every person has a given genetic mu